Dow Down 0.08% Nasdaq Up 0.31%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
0.92 Down 0.00(0.28%) 11:29AM EST - Nasdaq Real Time Price
Prev Close:0.92
Open:0.92
Bid:0.92 x 200
Ask:0.93 x 7400
1y Target Est:1.67
Beta:0.79
Next Earnings Date:N/A
Day's Range:0.92 - 0.93
52wk Range:0.85 - 2.20
Volume:19,922
Avg Vol (3m):242,198
Market Cap:47.63M
P/E (ttm):N/A
EPS (ttm):-1.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVEO

Comparison

Symbol% ChgMkt Cap
AVEODown 0.28%47.63M
AMGNUp 0.63%124.19B
PFEUp 0.59%193.11B
RHHBYUp 0.35%253.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.98
Quarterly EPS Est (Dec-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback